News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


PHARMAC steps up to help meet Government cancer treatment g

7 December 2012

Media release

PHARMAC steps up to help meet Government cancer treatment goal

Recent decisions by PHARMAC will have a positive effect on cancer treatment in New Zealand.

PHARMAC has removed the Special Authority funding requirements from seven cancer treatments, and from the diabetes treatment pioglitazone. Special Authorities define the clinical criteria patients must meet to receive some funded medicines. Clinicians must complete a Special Authority application and receive approval before prescribing in order for the patient to receive the funded medicine.

PHARMAC’s medical director Dr Peter Moodie, says the lifting of these funding restrictions is a positive step.

“Removing the Special Authorities from these cancer treatments will significantly reduce administrative demands on the hospital oncologists and haematologists who routinely prescribe these drugs,” says Dr Moodie.

“In addition, one of the medicines being de-restricted is capecitabine, a tablet which can be used in place of 5-flourouracil, a chemotherapy infusion that patients need to receive in hospitals or special treatment centres. Patients prescribed capecitabine will have a more convenient treatment option which they can take at home and this is particularly helpful for rural people and reduces their costs of receiving treatment.

“Removing the Special Authority restrictions will also free up hospital resources that can be used to treat more patients overall, which will help DHBs achieve the Government health priority to reduce cancer treatment waiting times.”

The medicines having Special Authority funding requirements removed are:

o Anagrelide hydrochloride – primarily used to treat thrombothycaemia (overproduction of platelets)

o Gemcitabine hydrochloride - used to treat a variety of cancers including bladder, breast, pancreas, lymphoma, lung and ovarian cancer.

o Irinotecan - primarily used to treat bowel and pancreatic cancer.

o Oxaliplatin - primarily used to treat bowel, pancreas and stomach cancer.

o Vinorelbine - primarily used to treat lymphoma, lung and breast cancer

o Capecitabine – primarily used to treat breast, bowel and stomach cancer

o Octreotide – primarily used in cancer for endocrine tumours and for palliation of symptoms in patients with malignant bowel obstruction.

Overall, removing the Special Authorities from these medicines will reduce the number of applications by about 4000 per year.

The Special Authorities were removed from these treatments from 1 December 2012 meaning that they are now fully funded by DHBs for any cancer patients. In addition, capecitabine is funded for any patient in the community when prescribed by a specialist.

Dr Moodie says that making access easier, such as by removing Special Authorities, usually results in more patients being prescribed the treatment.

“Effectively, this means we are giving doctors treating cancer greater discretion in how they choose to treat their patients, in the knowledge that it will be funded for them.”

Pioglitazone is a treatment that increases the body’s sensitivity to insulin, and is mainly used to treat Type 2 diabetes.

As with the cancer treatments, the Special Authority on pioglitazone was removed from 1 December.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Scoop Review Of Books: No Longer An Island

Simon Nathan reviews 'Zealandia: Our Continent Revealed': The idea that New Zealand is part of a large submerged continent is not new... There was renewed interest in the extent of offshore New Zealand from the 1970s onwards with the start of offshore drilling for oil and gas, and this was given impetus by a UN agreement which allowed countries to claim an Extended Continental Shelf (ECS). More>>

Art: Simon Denny Recreates Kim Dotcom’s Personal Effects

Who owns what? How has the internet changed our relation to the world? These are two of the many questions Simon Denny raises in the latest exhibition at the Adam Art Gallery, opening on Saturday 4 October. More>>

Theatre: The F Word: Sex Without The 'ism'

Sex without the 'ism' Okay, so the sexes are equal in the eyes of the law. What the F happens now? More>>

Scoop Review Of Books: Don’t Eat The Fish

On 'The Catch' by Michael Field What the ecologically edible lists don’t appear to take into account – and they should – is slavery... It’s not an easy read, but it’s definitely near the top of my listicle of “5 Political Books You Must Read This Year”. More>>

ALSO:

Caracals: Small Cats With Big Ears Arrive At Wellington Zoo

Visitors to Wellington Zoo will be able to see New Zealand’s first Caracals in the Zoo’s new Grassland Cats habitat, with a special visitor opening day on Saturday 27 September. More>>

ALSO:

Gordon Campbell: Classics - Tales From Moominvalley
Can’t speak for the reading end of it but the Moomins ( or maybe the story about Margaret Wise Brown) were the most enjoyable subject to think about and write about during these whole first 50 issues of Werewolf. For that reason – and because the Moomins always reward re-reading – I’ve decided to reprint it. The only added element is a link to an interesting hour long documentary about Tove Jansson. More>>

ALSO:

Repping In The Pacific: All Blacks And Manu Samoa To Play Historic Apia Test

The All Blacks will play Manu Samoa in Apia on Wednesday 8 July next year as part of both teams’ preparations for Rugby World Cup 2015. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news